You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

COLCHICINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for colchicine and what is the scope of freedom to operate?

Colchicine is the generic ingredient in ten branded drugs marketed by Annora Pharma, Aurobindo Pharma Ltd, Endo Operations, Granules, Hikma Intl Pharms, Scilex Pharms, Alkem Labs Ltd, Amneal Pharms, Dr Reddys, Hetero Labs Ltd V, Mylan, Strides Pharma, Watson Labs Inc, Zydus Pharms, Takeda Pharms Usa, Agepha Pharma Fz, Watson Labs, Merck, Ani Pharms, Beecham, Impax Labs, Novast Labs, Rising, Sandoz, and Lederle, and is included in thirty NDAs. There are thirty-six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Colchicine has eighty-one patent family members in twenty-five countries.

There are sixteen drug master file entries for colchicine. Thirty-three suppliers are listed for this compound. There is one tentative approval for this compound.

Drug Prices for COLCHICINE

See drug prices for COLCHICINE

Drug Sales Revenue Trends for COLCHICINE

See drug sales revenues for COLCHICINE

Recent Clinical Trials for COLCHICINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas Southwestern Medical CenterPhase 2
AZ Sint-Jan AVPhase 3
University Hospital, GhentPhase 3

See all COLCHICINE clinical trials

Generic filers with tentative approvals for COLCHICINE
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up0.6MG/5MLSOLUTION;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for COLCHICINE
Medical Subject Heading (MeSH) Categories for COLCHICINE
Paragraph IV (Patent) Challenges for COLCHICINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
GLOPERBA Oral Solution colchicine 0.6 mg/5 mL 210942 1 2020-04-02
COLCRYS Tablets colchicine 0.3 mg 022352 1 2019-07-19
MITIGARE Capsules colchicine 0.6 mg 204820 1 2016-06-10
COLCRYS Tablets colchicine 0.6 mg 022352 1 2011-12-23

US Patents and Regulatory Information for COLCHICINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agepha Pharma Fz LODOCO colchicine TABLET;ORAL 215727-001 Jun 16, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd COLCHICINE colchicine CAPSULE;ORAL 215463-001 Apr 29, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa COLCRYS colchicine TABLET;ORAL 022352-001 Jul 29, 2009 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Takeda Pharms Usa COLCRYS colchicine TABLET;ORAL 022352-001 Jul 29, 2009 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novast Labs PROBENECID AND COLCHICINE colchicine; probenecid TABLET;ORAL 040618-001 May 13, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Agepha Pharma Fz LODOCO colchicine TABLET;ORAL 215727-001 Jun 16, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for COLCHICINE

Country Patent Number Title Estimated Expiration
Brazil 112015010063 método para o tratamento ou prevenção de um evento cardiovascular em um sujeito com doença vascular aterosclerótica, utilização de um composto de fórmula (i), um derivado da colquicina conhecido e/ou um sal do mesmo, composição para a prevenção ou tratamento de um evento cardiovascular em um sujeito com doença vascular aterosclerótica, método e regime para reduzir ou prevenir a inflamação induzida por cristal de colesterol no interior das placas ateroscleróticas em um sujeito, regime para o tratamento ou prevenção de um acidente cardiovascular em um indivíduo ⤷  Sign Up
Mexico 2020012310 FORMULACIONES DE LIBERACION PROLONGADA DE COLCHICINA Y METODOS DE USO DE LAS MISMAS. (SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME.) ⤷  Sign Up
Japan 2015535264 コルヒチン誘導体の投与による心血管イベントの処置または予防 ⤷  Sign Up
Mexico 2015014656 FORMULACIONES DE LIBERACION PROLONGADA DE COLCHICINA Y METODOS DE USO DE LAS MISMAS. (SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME.) ⤷  Sign Up
European Patent Office 3964205 TRAITEMENT OU PRÉVENTION D'ÉVÉNEMENTS CARDIOVASCULAIRES (TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS) ⤷  Sign Up
China 105307643 Sustained-release formulations of colchicine and methods of using same ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.